43 related articles for article (PubMed ID: 8041134)
1. Effect of angiotensin II on human vascular smooth muscle cell growth.
Mii S; Ware JA; Mallette SA; Kent KC
J Surg Res; 1994 Jul; 57(1):174-8. PubMed ID: 8041134
[TBL] [Abstract][Full Text] [Related]
2. Regulation of MAP kinase activity by growth stimuli in vascular smooth muscle.
Langan EM; Youkey JR; Elmore JR; Franklin DP; Singer HA
J Surg Res; 1994 Jul; 57(1):215-20. PubMed ID: 8041141
[TBL] [Abstract][Full Text] [Related]
3. Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation.
Kyaw M; Yoshizumi M; Tsuchiya K; Kagami S; Izawa Y; Fujita Y; Ali N; Kanematsu Y; Toida K; Ishimura K; Tamaki T
Mol Pharmacol; 2004 Apr; 65(4):832-41. PubMed ID: 15044612
[TBL] [Abstract][Full Text] [Related]
4. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
[TBL] [Abstract][Full Text] [Related]
5. Phenotype dictates the growth response of vascular smooth muscle cells to pulse pressure in vitro.
Cappadona C; Redmond EM; Theodorakis NG; McKillop IH; Hendrickson R; Chhabra A; Sitzmann JV; Cahill PA
Exp Cell Res; 1999 Jul; 250(1):174-86. PubMed ID: 10388531
[TBL] [Abstract][Full Text] [Related]
6. Effect of calcitonin gene-related peptide on angiotensin II-induced proliferation of rat vascular smooth muscle cells.
Qin XP; Ye F; Hu CP; Liao DF; Deng HW; Li YJ
Eur J Pharmacol; 2004 Mar; 488(1-3):45-9. PubMed ID: 15044034
[TBL] [Abstract][Full Text] [Related]
7. alpha1-Adrenergic receptor stimulation of mitogenesis in human vascular smooth muscle cells: role of tyrosine protein kinases and calcium in activation of mitogen-activated protein kinase.
Hu ZW; Shi XY; Lin RZ; Chen J; Hoffman BB
J Pharmacol Exp Ther; 1999 Jul; 290(1):28-37. PubMed ID: 10381756
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in cell size.
Berk BC; Rao GN
J Cell Physiol; 1993 Feb; 154(2):368-80. PubMed ID: 8425918
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II and endothelin-1 increase fibroblast growth factor-2 mRNA expression in vascular smooth muscle cells.
Peifley KA; Winkles JA
Biochem Biophys Res Commun; 1998 Jan; 242(1):202-8. PubMed ID: 9439636
[TBL] [Abstract][Full Text] [Related]
10. Effects of statin treatment and withdrawal on angiotensin II-induced phosphorylation of p38 MAPK and ERK1/2 in cultured vascular smooth muscle cells.
Tristano AG; Castejon AM; Castro A; Cubeddu LX
Biochem Biophys Res Commun; 2007 Feb; 353(1):11-7. PubMed ID: 17161379
[TBL] [Abstract][Full Text] [Related]
11. Heparin rapidly and selectively regulates protein tyrosine phosphorylation in vascular smooth muscle cells.
Mishra-Gorur K; Castellot JJ
J Cell Physiol; 1999 Feb; 178(2):205-15. PubMed ID: 10048585
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of vascular hypertrophy.
Campbell JH; Tachas G; Black MJ; Cockerill G; Campbell GR
Basic Res Cardiol; 1991; 86 Suppl 1():3-11. PubMed ID: 2036094
[TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin II and thromboxane A2 on the production of matrix metalloproteinase by human aortic smooth muscle cells.
Takagishi T; Murahashi N; Azagami S; Morimatsu M; Sasaguri Y
Biochem Mol Biol Int; 1995 Feb; 35(2):265-73. PubMed ID: 7663380
[TBL] [Abstract][Full Text] [Related]
14. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells.
Mii S; Khalil RA; Morgan KG; Ware JA; Kent KC
Am J Physiol; 1996 Jan; 270(1 Pt 2):H142-50. PubMed ID: 8769745
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II stimulation of rapid protein tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells.
Molloy CJ; Taylor DS; Weber H
J Biol Chem; 1993 Apr; 268(10):7338-45. PubMed ID: 8385103
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase inhibitor, p21Waf1, regulates vascular smooth muscle cell hypertrophy.
Okamoto K; Kato S; Arima N; Fujii T; Morimatsu M; Imaizumi T
Hypertens Res; 2004 Apr; 27(4):283-91. PubMed ID: 15127886
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II stimulates collagen synthesis in human vascular smooth muscle cells. Involvement of the AT(1) receptor, transforming growth factor-beta, and tyrosine phosphorylation.
Ford CM; Li S; Pickering JG
Arterioscler Thromb Vasc Biol; 1999 Aug; 19(8):1843-51. PubMed ID: 10446062
[TBL] [Abstract][Full Text] [Related]
18. Heparin binding, internalization, and metabolism in vascular smooth muscle cells: II. Degradation and secretion in sensitive and resistant cells.
Letourneur D; Caleb BL; Castellot JJ
J Cell Physiol; 1995 Dec; 165(3):687-95. PubMed ID: 7593249
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of heparin on serotonin-induced hyperplasia and hypertrophy of smooth muscle cells.
Lee SL; Wang WW; Joseph PM; Hales CA; Fanburg BL
Am J Respir Cell Mol Biol; 1997 Jul; 17(1):78-83. PubMed ID: 9224212
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of rat vascular smooth muscle cell glycosaminoglycan production by angiotensin II.
Bailey WL; LaFleur DW; Forrester JS; Fagin JA; Sharifi BG
Atherosclerosis; 1994 Nov; 111(1):55-64. PubMed ID: 7840814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
